Home/Confluence Pharmaceuticals/Kenneth G. Payie, Ph.D., RAC

KG

Kenneth G. Payie, Ph.D., RAC

Director of CM&C

Confluence Pharmaceuticals

Therapeutic Areas

Fragile X Syndrome Autism Spectrum Disorder Neurodevelopmental Disorders

Leadership Team at Confluence Pharmaceuticals

Steven L. Johns

President and Founder

Boyd W. Sturdevant, Jr.

Chairman and Founder

Dr. Craig A. Erickson

Lead Scientific Advisor

Timothy F. Parshall

Vice President of Corporate Affairs

View full Confluence Pharmaceuticals profile